Excited to present 🎤 first data #SABCS24 from TONIC2. Follow-up from nature.com/articles/s4159…. Are immune induction with dox or cisplatin indeed benefiting pts? @VeerleGeurts at P1-7-30 and new data on acquired resist🔬 to aPD1 at PS17-09 @NKI_nl @OncoAlert @NatureMedicine
MarleenKokLab
@lab_kok
medical oncologist, breast cancer immunotherapy investigator, mother, PI and associate prof at NKI, happy in Amsterdam
458 Following 2K Followers 679 Posts
Latest posts 5
Recent Nature paper on phase of menstrual cycle at start of breast cancer chemo suggests that this can affect chemo-sensitivity. More research needed on how this can result in cycle-driven-chemo-start. 💊💉Congrats @vanRheenen_Lab @NKI_nl nature.com/articles/s4158…
This is well-deserved! Congrats @deVisserKarin 🥳🥳. She was one of the first scientists recognizing the importance of immune cells in breast tumors. Thanks to key leaders like Karin we now start doing trials specific for BC with high TILs #OPTImal study @NKI_nl @TILsWorkGroup
🎉 Congratulations to @deVisserKarin on receiving the prestigious 2025 Pezcoller-Marina Larcher Fogazzaro-EACR Women in Cancer Research Award! Karin’s groundbreaking work is internationally recognized ➡️ bit.ly/4frxcekView quoted post on X
Fantastic PhD program at amazing institution @NKI_nl 👇
📢 Applications for the NKI PhD program open from Jan 1 - Feb 28. Join our international research community in Amsterdam, working in cancer biology, AI research & life sciences with leading scientists and top facilities #PhD #CancerResearch More info: bit.ly/3O4bOjqView quoted post on X
Stellar line up of speakers and spot on discussions and clinical cases! In the beautiful town of Padua🇮🇹 #AIBCC24 with @MOliveira_MD @vitti10 @prat_aleix @hoperugo and many others!
One of the unmissable meeting of the year, over the past 20 years! #AIBCC24View quoted post on X
Now on stage @lab_kok on Immune system and #BreastCancer
@valeguarneri @prat_aleix @vitti10 @GaiaGriguolo @FedeMiglietta